Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 8.67B | 8.09B | 8.93B | 8.77B | 7.47B |
Gross Profit | 575.74M | 551.30M | 601.25M | 724.52M | 452.11M |
EBITDA | 479.81M | 502.60M | 453.10M | 594.99M | 317.92M |
Net Income | 269.54M | 291.70M | 219.67M | 309.85M | 155.82M |
Balance Sheet | |||||
Total Assets | 5.43B | 5.91B | 5.12B | 5.01B | 5.01B |
Cash, Cash Equivalents and Short-Term Investments | 1.32B | 1.78B | 1.48B | 1.39B | 1.44B |
Total Debt | 661.32M | 866.63M | 1.03B | 947.90M | 1.05B |
Total Liabilities | 1.96B | 2.17B | 2.06B | 2.20B | 2.14B |
Stockholders Equity | 3.47B | 3.74B | 3.05B | 2.80B | 2.87B |
Cash Flow | |||||
Free Cash Flow | 215.34M | 322.10M | 53.61M | 399.10M | 88.27M |
Operating Cash Flow | 216.07M | 348.60M | 87.01M | 420.98M | 167.36M |
Investing Cash Flow | -110.48M | 167.68M | -14.05M | -24.96M | -10.49M |
Financing Cash Flow | -567.94M | -218.41M | 14.84M | -444.13M | 141.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥2.64B | 8.43 | 2.97% | 7.17% | -2.93% | ||
73 Outperform | ¥4.61B | 9.75 | 3.79% | 3.73% | -18.84% | ||
70 Outperform | ¥4.70B | 46.50 | 1.73% | 0.65% | 4.36% | ||
70 Neutral | ¥4.89B | 8.85 | 0.55% | 3.30% | 54.50% | ||
58 Neutral | HK$14.16B | 4.53 | -3.01% | 6.82% | 3.67% | -54.16% | |
53 Neutral | ¥3.30B | 14.12 | ― | -21.81% | ― | ||
52 Neutral | ¥3.87B | ― | 2.67% | 20.63% | -2022.64% |